Expert: Pharmacy, Medical Benefit Adoption of Biosimilars Present Different Challenges

Fran Gregory, PharmD, MBA, vice president of Emerging Therapies at Cardinal Health, discussed the biosimilars landscape and where biosimilars fall in the process of pharmacy and medical benefit adoption.

Related Keywords

Fran Gregory ,Therapies At Cardinal Health ,Pharmacy Times ,Emerging Therapies ,Cardinal Health ,Oncology Care Model ,